AMANDA ORR: Open Payments
NPI 1952559007 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,424 in 77 payments from 17 companies in 2025. Trend: 2023 $173 · 2024 $91 · 2025 $1,424
Food & beverage: $1,357Education: $67
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $288 |
| Amgen Inc. | 16 | $196 |
| UCB, Inc. | 6 | $145 |
| Mallinckrodt Hospital Products Inc. | 3 | $118 |
| Celltrion USA Inc. | 4 | $113 |
| AstraZeneca Pharmaceuticals LP | 5 | $109 |
| Janssen Biotech, Inc. | 4 | $96 |
| Novartis Pharmaceuticals Corporation | 4 | $88 |
| E.R. Squibb & Sons, L.L.C. | 3 | $52 |
| Radius Health, Inc. | 3 | $51 |
Products named: RINVOQ, Bimzelx, ACTHAR, VEGZELMA, TREMFYA, SAPHNELO, SKYRIZI, ENBREL.
Industry payments across IN — which companies pay providers there.
